Colin J.D. Ross

12.5k total citations · 1 hit paper
217 papers, 7.4k citations indexed

About

Colin J.D. Ross is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Colin J.D. Ross has authored 217 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 51 papers in Pediatrics, Perinatology and Child Health and 50 papers in Genetics. Recurrent topics in Colin J.D. Ross's work include Pharmacogenetics and Drug Metabolism (30 papers), Pharmaceutical studies and practices (22 papers) and Cancer therapeutics and mechanisms (15 papers). Colin J.D. Ross is often cited by papers focused on Pharmacogenetics and Drug Metabolism (30 papers), Pharmaceutical studies and practices (22 papers) and Cancer therapeutics and mechanisms (15 papers). Colin J.D. Ross collaborates with scholars based in Canada, United States and Netherlands. Colin J.D. Ross's co-authors include Michael R. Hayden, Bruce Carleton, Shahrad R. Rassekh, Henk Visscher, Michael Rieder, Lara A. Boyd, Gideon Koren, Kristin L. Campbell, Cameron S. Mang and Patricia L. Chang and has published in prestigious journals such as Circulation, Nature Communications and Neuron.

In The Last Decade

Colin J.D. Ross

208 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

2022 178 citations Colin J.D. Ross et al. profile →

Peers

Countries citing papers authored by Colin J.D. Ross

Since Specialization

Citations

This map shows the geographic impact of Colin J.D. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin J.D. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin J.D. Ross more than expected).

Fields of papers citing papers by Colin J.D. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin J.D. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin J.D. Ross. The network helps show where Colin J.D. Ross may publish in the future.

Co-authorship network of co-authors of Colin J.D. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Colin J.D. Ross. A scholar is included among the top collaborators of Colin J.D. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin J.D. Ross. Colin J.D. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia 2025 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), (unknown), (unknown), Kathy H. Li, Shahrad R. Rassekh, Bruce Carleton, Colin J.D. Ross, Wyeth W. Wasserman, Catrina M. Loucks	0
2	Systemic delivery of proteins using novel peptides via the sublingual route 2024 ·Journal of Controlled Release ·Jiamin Wu, Natalie Jones, (unknown), Feng Zhao, (unknown), Zheng Tan, (unknown), (unknown), Jing Li, Tejinder Kaur, (unknown), Colin J.D. Ross, Sarah Hedtrich, Shyh‐Dar Li	5
3	Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4 2024 ·Computers in Biology and Medicine ·Ali Arab, Bahareh Kashani, (unknown), (unknown), (unknown), (unknown), (unknown), Wan‐Chun Chang, Catrina M. Loucks, Colin J.D. Ross, Bruce Carleton, Martin Ester	5
4	Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia 2023 ·Frontiers in Pharmacology ·Angela Wu, H Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J.D. Ross, Bruce Carleton	2
5	Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial 2023 ·Clinical Cancer Research ·Etan Orgel, Kristin R. Knight, Yueh‐Yun Chi, Jemily Malvar, Teresa Rushing, (unknown), Laurie S. Eisenberg, Shahrad R. Rassekh, Colin J.D. Ross, (unknown), Michael Neely, Edward A. Neuwelt, Leslie L. Muldoon, David R. Freyer	19
6	Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children 2023 ·Therapeutic Drug Monitoring ·(unknown), Beth Brooks, Shahrad R. Rassekh, (unknown), (unknown), Wei Xu, Catrina M. Loucks, Colin J.D. Ross, Bruce Carleton	4
7	Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients 2022 ·Pharmacogenomics ·(unknown), Bruce Carleton, Colin J.D. Ross, Mara Medeiros-Domingo, Gilberto Castañeda‐Hernández, Patricia Clark	5
8	Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics 2022 ·Pediatric Transplantation ·(unknown), Atul Sharma, (unknown), Colin J.D. Ross, Bruce Carleton, David S. Wishart, Mara Medeiros-Domingo, Tom Blydt‐Hansen	3
9	A Systematic Review of Polygenic Models for Predicting Drug Outcomes 2022 ·Journal of Personalized Medicine ·(unknown), (unknown), Shahrad R. Rassekh, Colin J.D. Ross, Bruce Carleton	10
10	COVID Face Masks and the Wuhan Lab Escape Theory: An Update 2021 ·Colin J.D. Ross, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
11	Misinformation Concerning Face Masks and the Wuhan Lab Leak 2021 ·Colin J.D. Ross, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
12	Thoughts on the Politics of COVID-19 2021 ·Colin J.D. Ross, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
13	How Misinformation that Facemasks are Effective for Reducing COVID-19 is Transmitted 2020 ·Colin J.D. Ross, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
14	Linkage analysis identifies an isolated strabismus locus at 14q12 overlapping with FOXG1 syndrome region 2020 ·Journal of Medical Genetics ·Xin Ye, Nicole M. Roslin, Andrew D. Paterson, Christopher J. Lyons, (unknown), Phillip A. Richmond, Casper Shyr, Oriol Fornés, Xiaohua Han, Michelle Higginson, Colin J.D. Ross, Deborah Giaschi, Cheryl Y. Gregory‐Evans, Millan S. Patel, Wyeth W. Wasserman	2
15	Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease 2020 ·Human Molecular Genetics ·Galen E.B. Wright, Nicholas S. Caron, Bernard Ng, (unknown), (unknown), Xiaohong Xu, Jolene Ooi, Mahmoud A. Pouladi, Sara Mostafavi, Colin J.D. Ross, Michael R. Hayden	18
16	Affectively Biased Competition: Sustained Attention is Tuned to Rewarding Expressions and is Not Modulated by Norepinephrine Receptor Gene Variant 2019 ·Collabra Psychology ·(unknown), (unknown), Colin J.D. Ross, Daniel J. Müller, Matthias J. Wieser, Rebecca M. Todd	0
17	Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis 2019 ·Arthritis & Rheumatology ·(unknown), Kimberly Morishita, Paul Dancey, Paul Moorehead, Britt I. Drögemöller, Xiaohua Han, Jinko Graham, Robert E. W. Hancock, Dirk Foell, Susanne M. Benseler, (unknown), Rae S. M. Yeung, Susan Shenoi, Marek Böhm, Alan Rosenberg, Colin J.D. Ross, David A. Cabral, Kelly L. Brown, (unknown)	38
18	Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients 2018 ·Clinical Cancer Research ·Britt I. Drögemöller, Beth Brooks, (unknown), Jose Gerard Monzon, Galen E.B. Wright, Geoffrey Liu, Daniel J. Renouf, Christian Kollmannsberger, Philippe L. Bédard, Michael R. Hayden, Karen A. Gelmon, Bruce Carleton, Colin J.D. Ross	28
19	More Codeine Fatalities After Tonsillectomy in North American Children 2012 ·PEDIATRICS ·Lauren E. Kelly, Michael Rieder, John van den Anker, (unknown), Colin J.D. Ross, Michael Neely, Bruce Carleton, Michael R. Hayden, Parvaz Madadi, Gideon Koren	273
20	Intramuscular Administration of AAV1-Lipoprotein Lipase ^S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients 2008 ·Arteriosclerosis Thrombosis and Vascular Biology ·Erik S.G. Stroes, Melchior C. Nierman, J. J. M. Meulenberg, Remco Franssen, Jaap Twisk, C. P. Henny, Mario Maas, Aeilko H. Zwinderman, Colin J.D. Ross, Eleonora Aronica, Katherine A. High, Marcel M. Levi, Michael R. Hayden, John J.P. Kastelein, Jan Albert Kuivenhoven	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact